Search research articles
Contact Us
Filters
Showing results (71-80 of 144) with videos related to
Page
of 15
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
March 26, 2008
Intraventricular enzyme replacement improves disease phenotypes in a mouse model of late infantile neuronal ceroid lipofuscinosis
Michael Chang, Jonathan D Cooper, David E Sleat, et al.
The Journal of Biological Chemistry
|
February 25, 2010
DHHC5 interacts with PDZ domain 3 of post-synaptic density-95 (PSD-95) protein and plays a role in learning and memory
Yi Li, Jie Hu, Klemens Höfer, et al.
Journal of Neuropathology and Experimental Neurology
|
December 20, 2007
Synaptic changes in the thalamocortical system of cathepsin D-deficient mice: a model of human congenital neuronal ceroid-lipofuscinosis
Sanna Partanen, Aleksi Haapanen, Catherine Kielar, et al.
Journal of Biomolecular NMR
|
April 5, 2011
A metabolomic comparison of mouse models of the Neuronal Ceroid Lipofuscinoses
Reza M Salek, Michael R Pears, Jonathan D Cooper, et al.
Neurobiology of Disease
|
October 31, 2006
IgG entry and deposition are components of the neuroimmune response in Batten disease
Ming J Lim, Noreen Alexander, Jared W Benedict, et al.
Neurobiology of Disease
|
October 19, 2006
Successive neuron loss in the thalamus and cortex in a mouse model of infantile neuronal ceroid lipofuscinosis
Catherine Kielar, Lucy Maddox, Ellen Bible, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
December 21, 2005
CNS-directed AAV2-mediated gene therapy ameliorates functional deficits in a murine model of infantile neuronal ceroid lipofuscinosis
Megan A Griffey, David Wozniak, Michael Wong, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
September 1, 2015
Microglial activation in the rat brain following chronic antipsychotic treatment at clinically relevant doses
Marie-Caroline Cotel, Ewelina M Lenartowicz, Sridhar Natesan, et al.
Annals of Neurology
|
November 3, 2016
Efficacy of phosphodiesterase-4 inhibitors in juvenile Batten disease (CLN3)
Amy Aldrich, Megan E Bosch, Rachel Fallet, et al.
Frontiers in Neurology
|
October 2, 2019
Combined Anti-inflammatory and Neuroprotective Treatments Have the Potential to Impact Disease Phenotypes in <i>Cln3</i> <sup>-/-</sup> Mice
Marta A Tarczyluk-Wells, Christoph Salzlechner, Allison R Najafi, et al.
Page
of 15
Search research articles
Search
Showing results (71-80 of 144) with videos related to
Sort By:
Page
of 15
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
March 26, 2008
Intraventricular enzyme replacement improves disease phenotypes in a mouse model of late infantile neuronal ceroid lipofuscinosis
Michael Chang, Jonathan D Cooper, David E Sleat, et al.
The Journal of Biological Chemistry
|
February 25, 2010
DHHC5 interacts with PDZ domain 3 of post-synaptic density-95 (PSD-95) protein and plays a role in learning and memory
Yi Li, Jie Hu, Klemens Höfer, et al.
Journal of Neuropathology and Experimental Neurology
|
December 20, 2007
Synaptic changes in the thalamocortical system of cathepsin D-deficient mice: a model of human congenital neuronal ceroid-lipofuscinosis
Sanna Partanen, Aleksi Haapanen, Catherine Kielar, et al.
Journal of Biomolecular NMR
|
April 5, 2011
A metabolomic comparison of mouse models of the Neuronal Ceroid Lipofuscinoses
Reza M Salek, Michael R Pears, Jonathan D Cooper, et al.
Neurobiology of Disease
|
October 31, 2006
IgG entry and deposition are components of the neuroimmune response in Batten disease
Ming J Lim, Noreen Alexander, Jared W Benedict, et al.
Neurobiology of Disease
|
October 19, 2006
Successive neuron loss in the thalamus and cortex in a mouse model of infantile neuronal ceroid lipofuscinosis
Catherine Kielar, Lucy Maddox, Ellen Bible, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
December 21, 2005
CNS-directed AAV2-mediated gene therapy ameliorates functional deficits in a murine model of infantile neuronal ceroid lipofuscinosis
Megan A Griffey, David Wozniak, Michael Wong, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
September 1, 2015
Microglial activation in the rat brain following chronic antipsychotic treatment at clinically relevant doses
Marie-Caroline Cotel, Ewelina M Lenartowicz, Sridhar Natesan, et al.
Annals of Neurology
|
November 3, 2016
Efficacy of phosphodiesterase-4 inhibitors in juvenile Batten disease (CLN3)
Amy Aldrich, Megan E Bosch, Rachel Fallet, et al.
Frontiers in Neurology
|
October 2, 2019
Combined Anti-inflammatory and Neuroprotective Treatments Have the Potential to Impact Disease Phenotypes in <i>Cln3</i> <sup>-/-</sup> Mice
Marta A Tarczyluk-Wells, Christoph Salzlechner, Allison R Najafi, et al.
Page
of 15